Therapeutic applications of guanylate cyclase-C receptor agonists

Current Opinion in Drug Discovery and Development

Volumn 5, Issue 2, 2002, Pages 261-268

  Shailubhai, Kunwar ^a  

^a Synergy Pharmaceuticals Inc   (United States)

Author keywords

Asthma; Cancer; cGMP; Guanylate cyclase C; Guanylin; Heat stable enterotoxin ST; Inflammation; Uroguanylin

Indexed keywords

CYCLIC GMP; ENDOTOXIN; GUANYLATE CYCLASE; GUANYLATE CYCLASE C; GUANYLATE CYCLASE C RECEPTOR; GUANYLIN; LYMPHOGUANYLIN; RECEPTOR; UNCLASSIFIED DRUG; UROGUANYLIN;

CARCINOGENESIS; COLON CARCINOMA; COLON POLYP; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; INFLAMMATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; GUANYLATE CYCLASE; HUMANS; LUNG DISEASES; MOLECULAR SEQUENCE DATA; NEOPLASMS;

EID: 0036489782     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Guanylin regulatory peptides: Structures, biological activities mediated by cyclic GMP and pathobiology
2. The guanylin and uroguanylin peptide hormones and their receptors
3. Lymphoguanylin: Cloning and characterization of a unique member of the guanylin peptide family
4. Guanylin: An endogenous activator of intestinal guanylate cyclase
5. Human guanylin: cDNA isolation, structure, and activity
6. Prouroguanylin and proguanylin: Purification from colon, structure, and modulation of bioactivity by proteases
7. Mechanisms of guanylin action via cyclic GMP in the kidney
8. Guanylin: A peptide regulator of epithelial transport
9. mini+ mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP
10. mini+ mouse by a novel mechanism involving induction of apoptosis in epithelial cells of the intestinal mucosa
11. Uroguanylin induces apoptosis in human colon carcinoma cells via a cGMP-dependent mechanism
12. Epithelial renewal in premalignant conditions of the gastrointestinal tract: A review
13. Signal transduction pathways via guanylin and uroguanylin in stomach and intestine
14. Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity
15. Regulation of intestinal Cl- and HCO3-secretion by uroguanylin
16. Guanylin family: New intestinal peptides regulating electrolyte and water homeostasis
17. Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin
18. Enterochromaffin-like cells, a cellular source of uroguanylin in rat stomach
19. Acid-stimulated duodenal bicarbonate secretion involves a CFTR-mediated transport pathway in mice
20. Gastric cell regeneration
21. Top-down morphogenesis of colorectal tumors
22. Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells
23. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells
24. A necessary role for cell shrinkage in apoptosis
25. Ion homeostasis and apoptosis
26. + channels induces apoptosis in vascular smooth muscle cells
27. + efflux in the activation of apoptosis
28. Volume regulation and ion transport during apoptosis
29. Cell volume regulation in immune cell apoptosis
30. Effect of pH, ionic charge, and osmolality on cytochrome c-mediated caspase-3 activity
31. Activation of potassium and chloride channels by tumor necrosis factor-α. Role in liver cell death
32. + suppresses the activation of apoptosis in lymphocytes
33. Differential involvement of initiator caspases in apoptotic volume decrease and potassium efflux during Fas- and UV-induced cell death
34. Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo
35. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism
36. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes
37. Colonic cell proliferation, differentiation, and apoptosis
38. Cell differentiation and the development of colonic neoplasms
39. Mapping of guanylin to murine chromosome 4 and human chromosome 1p34-p35
40. The uroguanylin gene (Guca1b) is linked to guanylin (Guca2) on mouse chromosome 4
41. Human colorectal cancer: High frequency of deletions at chromosome 1p35
42. Guanylin mRNA expression in human intestine and colorectal adenocarcinoma
43. Gene expression profiles in normal and cancer cells
44. Expression of guanylin is downregulated in mouse and human intestinal adenomas
45. Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated β-catenin
46. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis
47. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites
48. Sulindac and its derivatives: A novel class of anticancer agents
49. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues
50. The guanylin/STa receptor is expressed in crypts and apical epithelium throughout the mouse intestine
51. Internalization of E. coli ST mediated by guanylyl cyclase C in T84 human colon carcinoma cells
52. 111In-labeled ST-peptide enterotoxin (ST) analogue for specific targeting of guanylin receptors on human colonic cancers
53. 111In-labeled ST-peptide analog for specific-targeting of human colon cancers
54. Uroguanylin and guanylate cyclase C in the human pancreas: Expression and mutuality of ligand/receptor localization as indicators of intercellular paracrine signaling pathways
55. Escherichia coli heat-stable enterotoxins, guanylins, and their receptors: What are they and what do they do?
56. Both inhalant and intravenous uroguanylin inhibit leukotriene C4-induced airway changes
57. Role of leukotrienes and leukotriene receptor antagonist in asthma: New advances
58. Effects of uroguanylin and guanylin against antigen-induced bronchoconstriction and airway microvascular leakage in sensitized guinea-pigs
59. Compared effects of natriuretic peptides on ovalbumin-induced asthmatic model
60. Millennium in-licenses novel target for colorectal cancer